Spyre Therapeutics
SYRE
SYRE
38 hedge funds and large institutions have $84.1M invested in Spyre Therapeutics in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 0 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
38
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.48M | |
| 2 | +$1.11M | |
| 3 | +$694K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$656K |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$649K |
Top Sellers
| 1 | -$1.89M | |
| 2 | -$85K | |
| 3 | -$72K | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$9K |